XOMA Royalty (XOMA) Cash from Investing Activities (2010 - 2026)

XOMA Royalty's (XOMA) quarterly Cash from Investing Activities came in at $6.6 million in Q1 2026, up 197.89% year-on-year from $2.2 million in Q1 2025, and down 66.13% quarter-over-quarter from $19.3 million in Q4 2025.

XOMA Royalty (XOMA) Cash from Investing Activities (2010 - 2026) Analysis & Trends

XOMA Royalty has disclosed Cash from Investing Activities across 16 years of filings, most recently posting $6.6 million for Q1 2026.

  • Cash from Investing Activities for Q1 2026 came in at $6.6 million, up 197.89% year-over-year; the trailing twelve-month figure through Mar 2026 was $64.1 million (up 331.47% YoY), and the FY2025 annual result was $50.9 million, up 280.07% from the prior year.
  • Cash from Investing Activities came in at $6.6 million for Q1 2026 at XOMA Royalty, down from $19.3 million in the prior quarter.
  • In the past five years, Cash from Investing Activities ranged from a high of $58.2 million in Q3 2025 to a low of -$36.4 million in Q4 2024.
  • The 5-year median for Cash from Investing Activities is -$2.2 million (2022), against an average of $515437.5.
  • Across the five-year window, Cash from Investing Activities jumped 21030.77% in 2023 and sank 761.06% in 2024, its largest moves.
  • XOMA Royalty's Cash from Investing Activities stood at -$15.2 million in 2022, then soared by 136.14% to $5.5 million in 2023, then tumbled by 761.06% to -$36.4 million in 2024, then surged by 153.11% to $19.3 million in 2025, then tumbled by 66.13% to $6.6 million in 2026.
  • The last three Cash from Investing Activities figures came in at $6.6 million (Q1 2026), $19.3 million (Q4 2025), and $58.2 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing (Qtr)
1 Alterity Therapeutics 762,369.55 Bn 762,369.51 Bn - -
2 Belite Bio 55,096.00 Bn 55,096.00 Bn - -
3 Quantum Biopharma 17,755.80 Bn 17,755.79 Bn - -2.89 Mn
4 Legend Biotech 3,486.00 Bn 3,485.71 Bn 242.10 Mn 638.50 Mn
5 Akari Therapeutics 1,737.42 Bn 1,737.41 Bn - -
6 Evaxion A 1,551.28 Bn 1,551.26 Bn - -
7 Psyence Biomedical 227.32 Bn 227.31 Bn - -
8 Vertex Pharmaceuticals 110.84 Bn 103.59 Bn 2.59 Bn -431.90 Mn
9 Abivax 91.71 Bn 91.71 Bn - 579,519.10
10 XOMA Royalty 5.48 Mn -60.60 Mn - 6.55 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 6.55 Mn
Mar 31, 2026 6.55 Mn
Dec 31, 2025 19.35 Mn
Dec 31, 2025 19.35 Mn
Sep 30, 2025 58.21 Mn
Sep 30, 2025 58.21 Mn
Jun 30, 2025 -19.98 Mn
Jun 30, 2025 -19.98 Mn
Mar 31, 2025 -6.69 Mn
Mar 31, 2025 -6.69 Mn
Dec 31, 2024 -36.43 Mn
Dec 31, 2024 -36.43 Mn
Sep 30, 2024 9.52 Mn
Sep 30, 2024 9.52 Mn
Jun 30, 2024 5.90 Mn
Jun 30, 2024 5.90 Mn
Mar 31, 2024 -7.25 Mn
Mar 31, 2024 -7.25 Mn
Dec 31, 2023 5.51 Mn
Dec 31, 2023 5.51 Mn